A 39-year-old construction worker, maintained on chronic high-dose oral morphine therapy for severe lumbar radiculopathy, presents to the emergency department after sustaining a traumatic anterior shoulder dislocation. For pre-procedural analgesia prior to joint reduction, the attending physician administers a standard intravenous dose of buprenorphine. Within fifteen minutes, the patient begins exhibiting profound diaphoresis, mydriasis, piloerection, and intense psychomotor agitation. Vital signs reveal a heart rate of 128/min and blood pressure of 168/98 mmHg. Which of the following pharmacologic principles best explains the mechanism underlying this patient's acute clinical deterioration?
- The administered agent has a lower dissociation constant () and a lower maximal efficacy () than the maintenance medication.Answer
- BThe administered agent has a higher dissociation constant () and an equivalent maximal efficacy () compared to the maintenance medication.
- CThe administered agent acts as a noncompetitive antagonist, lowering the maximal efficacy () without altering the dissociation constant ().
- DThe administered agent rapidly induces hepatic biotransformation, increasing the elimination rate constant () of the maintenance medication.
- EThe administered agent competitively inhibits cytochrome P450 enzymes, resulting in a sudden increase in the steady-state plasma concentration () of the maintenance medication.
Answer
The administered analgesic displaces the home medication because it has a higher receptor affinity (a lower dissociation constant, ) but precipitates withdrawal because it produces a weaker biological response (a lower maximal efficacy, ).
The correct answer identifies that the administered drug (buprenorphine) displaces the maintenance drug (morphine) because it binds more tightly to the receptor, reflected by a lower dissociation constant (). However, because it is only a partial agonist, it cannot fully activate the receptor, meaning it has a lower maximal efficacy (). In an opioid-dependent patient, this sudden replacement of a high-efficacy drug with a low-efficacy drug causes a massive net drop in mu-opioid receptor signaling, instantly precipitating withdrawal.
Step-by-Step Solution
Key Concept
Buprenorphine is a partial mu-opioid agonist with a lower dissociation constant (, indicating higher affinity) and a lower maximum efficacy () than full agonists like morphine, allowing it to precipitate withdrawal in opioid-dependent patients.